105 related articles for article (PubMed ID: 19317218)
21. Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation.
Nauck M; Warnick GR; Rifai N
Clin Chem; 2002 Feb; 48(2):236-54. PubMed ID: 11805004
[TBL] [Abstract][Full Text] [Related]
22. [Studies on the development of clinical laboratory tests by mathematical approaches: final lecture].
Okada M
Rinsho Byori; 2012 Jun; 60(6):536-41. PubMed ID: 22880231
[TBL] [Abstract][Full Text] [Related]
23. [Development of measurement methods and contributions to medical care in the clinical laboratory].
Sugiuchi H
Rinsho Byori; 2008 Jan; 56(1):66-71. PubMed ID: 18318234
[TBL] [Abstract][Full Text] [Related]
24. Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2.
Santos RD; Waters DD; Tarasenko L; Messig M; Jukema JW; Ferrières J; Verdejo J; Chiang CW;
Am Heart J; 2009 Nov; 158(5):860-6. PubMed ID: 19853709
[TBL] [Abstract][Full Text] [Related]
25. Improved specificity of a new homogeneous assay for LDL-cholesterol in serum with abnormal lipoproteins.
Iwasaki Y; Matsuyama H; Nakashima N
Clin Chem; 2006 May; 52(5):886-8. PubMed ID: 16556687
[TBL] [Abstract][Full Text] [Related]
26. The patient at risk: who should we be treating?
Leitersdorf E
Br J Clin Pract Suppl; 1994 Dec; (77):24-7. PubMed ID: 19496269
[TBL] [Abstract][Full Text] [Related]
27. Strategies for optimizing lipid management.
Ballantyne CM
Postgrad Med; 2004 Sep; 116(3 Suppl):13-20. PubMed ID: 19667671
[TBL] [Abstract][Full Text] [Related]
28. Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype.
Rizzo M; Berneis K; Hersberger M; Pepe I; Di Fede G; Rini GB; Spinas GA; Carmina E
Hum Reprod; 2009 Sep; 24(9):2286-92. PubMed ID: 19454589
[TBL] [Abstract][Full Text] [Related]
29. Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study).
Cui Y; Watson DJ; Girman CJ; Shapiro DR; Gotto AM; Hiserote P; Clearfield MB
Am J Cardiol; 2009 Sep; 104(6):829-34. PubMed ID: 19733719
[TBL] [Abstract][Full Text] [Related]
30. Better heart attack prediction from new cholesterol test? Two simple tests could someday elbow aside, or at least complement, today's standard cholesterol tests.
Harv Heart Lett; 2006 Jun; 16(10):3. PubMed ID: 16791941
[No Abstract] [Full Text] [Related]
31. The predictive role of atherogenic dyslipidemia in subjects with non-coronary atherosclerosis.
Berneis K; Rizzo M; Spinas GA; Di Lorenzo G; Di Fede G; Pepe I; Pernice V; Rini GB
Clin Chim Acta; 2009 Aug; 406(1-2):36-40. PubMed ID: 19433079
[TBL] [Abstract][Full Text] [Related]
32. A pilot randomized trial comparing an intensive versus a standard intervention in stable HIV-infected patients with moderate-high cardiovascular risk.
Masiá M; Bernal E; Padilla S; García N; Escribano JC; Martínez E; Gutiérrez F
J Antimicrob Chemother; 2009 Sep; 64(3):589-98. PubMed ID: 19625372
[TBL] [Abstract][Full Text] [Related]
33. Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels.
Grover SA; Kaouache M; Joseph L; Barter P; Davignon J
Arch Intern Med; 2009 Oct; 169(19):1775-80. PubMed ID: 19858435
[TBL] [Abstract][Full Text] [Related]
34. Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: the 2L cardio registry.
Gitt AK; Juenger C; Jannowitz C; Karmann B; Senges J; Bestehorn K
Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):438-44. PubMed ID: 19369876
[TBL] [Abstract][Full Text] [Related]
35. Low-density lipoprotein cholesterol estimation by a new formula--confirmation.
Gasko R
Int J Cardiol; 2007 Jul; 119(2):242-3; author reply 244. PubMed ID: 17049650
[TBL] [Abstract][Full Text] [Related]
36. [JUPITER can yield paradigmatic shift in the prevention of cardiovascular disease. Focus on inflammation as a risk factor].
Olsson AG
Lakartidningen; 2009 May 20-Jun 2; 106(21-22):1471-5. PubMed ID: 19579435
[No Abstract] [Full Text] [Related]
37. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C;
Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835
[TBL] [Abstract][Full Text] [Related]
38. [Significance of clinical pathology in the field of internal medicine].
Teramoto T
Rinsho Byori; 2011 Mar; 59(3):273-8. PubMed ID: 21748903
[No Abstract] [Full Text] [Related]
39. Low levels of low-density lipoprotein cholesterol and blood pressure and progression of coronary atherosclerosis.
Chhatriwalla AK; Nicholls SJ; Wang TH; Wolski K; Sipahi I; Crowe T; Schoenhagen P; Kapadia S; Tuzcu EM; Nissen SE
J Am Coll Cardiol; 2009 Mar; 53(13):1110-5. PubMed ID: 19324254
[TBL] [Abstract][Full Text] [Related]
40. Plasma PAF-acetylhydrolase activity, inflammatory markers and susceptibility of LDL to in vitro oxidation in patients with type 1 diabetes mellitus.
Gomes MB; Cobas RA; Nunes E; Castro-Faria-Neto HC; da Matta MF; Neves R; Tibiriçá E
Diabetes Res Clin Pract; 2009 Jul; 85(1):61-8. PubMed ID: 19464746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
